Treffer 1 - 2 von 2 für Suche 'Gnanasegaran, Soorya', Suchdauer: 0,31s Treffer weiter einschränken
  1. 1
    Targeting LLT1 as a potential immunotherapy option for cancer patients non-responsive to existing checkpoint therapies in multiple solid tumors

    Targeting LLT1 as a potential immunotherapy option for cancer patients non-responsive to existing checkpoint therapies in multiple solid tumors von Mandal, Tirtha, Gnanasegaran, Soorya, Rodrigues, Golding, Kashipathi, Shalini, Tiwari, Anurag, Dubey, Ashvini Kumar, Bhattacharjee, Sanghamitra, Manjunath, Yogendra, Krishna, Subith, Madhusudhan, M S, Ghosh, Maloy

    Veröffentlicht in BMC cancer

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    719 Phase 1 clinical trial design of ZM008, a first-in-class anti LLT1 antibody is a promising therapy for multiple solid cancers

    719 Phase 1 clinical trial design of ZM008, a first-in-class anti LLT1 antibody is a promising therapy for multiple solid cancers von Ghosh, Maloy, Tiwari, Anurag, Dubey, Ashvini Kumar, Bhattacharjee, Sanghamitra, Manjunath, Yogendra, Kashipathi, Shalini, Krishna, Subith, Mandal, Tirtha, Gnanasegaran, Soorya, Garcia-Ribas, Ignacio


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: